Craniopharyngioma

This Board is dedicated to those who are or were afflicted with #craniopharyngioma (CP), a rare benign #braintumor which can be aggressive and recur despite…

1,735 Pins

Collection by

Tara Tan

“An optician’s appointment saved my life”

Exploring Precision Medicine in Primary Brain Tumors. #Craniopharyngiomas and Precision Medicine (MAY 17, 2018)

Clinical trials

3 Pins

Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK/ERK pathway as a novel therapeutic target

Trametinib

1 Pin

Similar ideas popular now

Craniopharyngiomas are rare, slow-growing tumours located in the sellar region of the brain with a worldwide incidence rate of 1.34 per million. Here, a case is discussed that adds to the literature ...

Craniopharyngiomas are intracranial tumours with a bimodal peak prevalence in childhood and in later life. Although essentially benign pathologically, craniopharyngiomas can be highly invasive, tend to recur, and are often therapeutically highly complex.1,2 Additionally, hypothalamic sequelae can be highly problematic, certainly much more than for pituitary adenomas, also known as pituitary neuroendocrine tumours. Classically, the treatment of choice was radical surgery whenever possible, ... Cohort Study, Meta Analysis, Protons, Oncology, Pediatrics, Surgery, Peak, Complex

Craniopharyngiomas are intracranial tumours with a bimodal peak prevalence in childhood and in later life. Although essentially benign pathologically, craniopharyngiomas can be highly invasive, tend to recur, and are often therapeutically highly complex.1,2 Additionally, hypothalamic sequelae can be highly problematic, certainly much more than for pituitary adenomas, also known as pituitary neuroendocrine tumours. Classically, the treatment of choice was radical surgery whenever possible, ...

St. Jude Children's Research Hospital is reporting phase 2 clinical trial results treating the brain tumor craniopharyngioma with proton therapy.

Cognitive Domain

Brain Tissue

Improve Cognitive Function

Radiation Therapy

Hormone Replacement Therapy

Medical News

Hormone Imbalance

Clinical trial improves neurocognitive outcomes for childhood craniopharyngioma – Life Technology™

First longitudinal proton therapy study for children with craniopharyngioma

New Treatment Could Be Safer Way to Fight Brain Tumors in Kids

Learning Ability

Proton Radiation

Psychology Department

Hispanic Women

New Treatment Could Be Safer Way to Fight Brain Tumors in Kids

Wet keratin is a hallmark of adamantinomatous craniopharyngioma (ACP), which is frequently infiltrated by inflammatory cells. S100 calcium‑binding protein A9 (S100A9) has been confirmed to play a decisive role in the development of inflammation. However, the relationship between wet keratin (keratin nodules) and S100A9 in ACP is poorly understood. The objective of the present study was to explore the expression of S100A9 in ACP and its association with wet keratin formation. ... Drug Intervention, Causes Of Female Infertility, Intravenous Injection, Nucleus Accumbens, Androgen Receptor, Gestational Hypertension, Peptic Ulcer, Parasympathetic, Psychological Stress

Drug Intervention

Causes Of Female Infertility

Intravenous Injection

Nucleus Accumbens

Androgen Receptor

Gestational Hypertension

Peptic Ulcer

Parasympathetic

Psychological Stress

Wet keratin is a hallmark of adamantinomatous craniopharyngioma (ACP), which is frequently infiltrated by inflammatory cells. S100 calcium‑binding protein A9 (S100A9) has been confirmed to play a decisive role in the development of inflammation. However, the relationship between wet keratin (keratin nodules) and S100A9 in ACP is poorly understood. The objective of the present study was to explore the expression of S100A9 in ACP and its association with wet keratin formation. ...

Craniopharyngioma is a brain tumor arising in the region of the hypothalamic-pituitary axis. Children and adolescents with craniopharyngioma have high survival rates, but often experience significant morbidity, including high rates of sleep disorders. Vulnerabilities to circadian disruption are present in this population, but little is known about circadian health. We present exploratory circadian findings from a prospective trial at a single center. Data presented here are from the baseline ... Circadian Rhythm, Adolescence, Axis, Vulnerability, Disorders

Craniopharyngioma is a brain tumor arising in the region of the hypothalamic-pituitary axis. Children and adolescents with craniopharyngioma have high survival rates, but often experience significant morbidity, including high rates of sleep disorders. Vulnerabilities to circadian disruption are present in this population, but little is known about circadian health. We present exploratory circadian findings from a prospective trial at a single center. Data presented here are from the baseline ...

Craniopharyngioma - MEDizzy

Funds raised for Sheffield Children's Hospital that saved Huddersfield girl's life - BBC News

Fundraising

Save

Funds raised for Sheffield Children's Hospital that saved Huddersfield girl's life - BBC News

Brain Surgery

Academy Figure

Scott Hamilton

Important Life Lessons

Seattle Kraken Skating Academy figure skater has brain tumor | king5.com

Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College of Medicine have identified a biomarker that can be used in blood tests to diagnose GBM, track its progression and guide treatment. The researchers said that such a non-invasive liquid biopsy for GBM could help patients get the care they need more quickly. Thyroid Test, Thyroid Health, Low Thyroid, Thyroid Cancer, Diagnosing Fibromyalgia, Hypothyroidism Symptoms, Nclex Study Plan, Overactive Thyroid, Natural Remedies

Diagnosing Fibromyalgia

Hypothyroidism Symptoms

Nclex Study Plan

Overactive Thyroid

Natural Remedies

Glioblastoma (GBM) is the most common and deadliest type of brain cancer with a five-year survival rate of only 5%. Researchers at Penn State College of Medicine have identified a biomarker that can be used in blood tests to diagnose GBM, track its progression and guide treatment. The researchers said that such a non-invasive liquid biopsy for GBM could help patients get the care they need more quickly.